British Journal of Cancer - Table of Contents alert Volume 114 Issue 10

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 114, Issue 10 (1069-1174) Published online 10 May 2016 In this issue Editorial Minireview Clinical Studies Translational Therapeutics Molecular Diagnostics Genetics and Genomics Letters to the Editor Also new today Advance online publication Digital Edition Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement BJC collections: Cancer Immunotherapy Immunotherapies have revolutionised therapy for some cancers. In parallel with therapeutic trials, many other mechanisms and pathways are being investigated in optimising these treatments.  Access this collection from British Journal of Cancer - free online for six months Produced with support from: EMD Serono Editorial Top New prostate cancer grade group system correlates with prostate cancer death in addition to biochemical recurrence Jonathan I Epstein Br J Cancer 2016 114: 1069-1070; 10.1038/bjc.2016.102 Full Text Minireview Top Hypoxia-activated prodrugs: paths forward in the era of personalised medicine Francis W Hunter, Bradly G Wouters and William R Wilson Br J Cancer 2016 114: 1071-1077; advance online publication, April 12, 2016; 10.1038/bjc.2016.79 Abstract | Full Text Clinical Studies Top Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome Daniel M Berney, Luis Beltran, Gabrielle Fisher, Bernard V North, David Greenberg, Henrik Møller, Geraldine Soosay, Peter Scardino and Jack Cuzick on behalf of the Transatlantic Prostate Group Br J Cancer 2016 114: 1078-1083; advance online publication, April 21, 2016; 10.1038/bjc.2016.86 Abstract | Full Text Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy S Bowyer, P Prithviraj, P Lorigan, J Larkin, G McArthur, V Atkinson, M Millward, M Khou, S Diem, S Ramanujam, B Kong, E Liniker, A Guminski, P Parente, M C Andrews, S Parakh, J Cebon, G V Long, M S Carlino and O Klein Br J Cancer 2016 114: 1084-1089; advance online publication, April 28, 2016; 10.1038/bjc.2016.107 Abstract | Full Text Translational Therapeutics Top Mitochondrial dysfunction-mediated apoptosis resistance associates with defective heat shock protein response in African–American men with prostate cancer Ajay K Chaudhary, Tariq A Bhat, Sandeep Kumar, Anil Kumar, Rahul Kumar, Willie Underwood, Shahriar Koochekpour, Mojgan Shourideh, Neelu Yadav, Shanta Dhar and Dhyan Chandra Br J Cancer 2016 114: 1090-1100; advance online publication, April 26, 2016; 10.1038/bjc.2016.88 Abstract | Full Text Metastasis-inducing proteins are widely expressed in human brain metastases and associated with intracranial progression and radiation response Rasheed Zakaria, Angela Platt-Higgins, Nitika Rathi, Daniel Crooks, Andrew Brodbelt, Emmanuel Chavredakis, David Lawson, Michael D Jenkinson and Philip S Rudland Br J Cancer 2016 114: 1101-1108; advance online publication, April 21, 2016; 10.1038/bjc.2016.103 Abstract | Full Text Expression of breast cancer stem cell markers as predictors of prognosis and response to trastuzumab in HER2-positive breast cancer An Na Seo, Hee Jin Lee, Eun Joo Kim, Min Hye Jang, Yu Jung Kim, Jee Hyun Kim, Sung-Won Kim, Han Suk Ryu, In Ae Park, Seock-Ah Im, Gyungyub Gong, Kyung Hae Jung, Hee Jeong Kim and So Yeon Park Br J Cancer 2016 114: 1109-1116; advance online publication, April 26, 2016; 10.1038/bjc.2016.101 Abstract | Full Text Molecular Diagnostics Top Expression of the chemokine CXCL14 in the tumour stroma is an independent marker of survival in breast cancer Elin Sjöberg, Martin Augsten, Jonas Bergh, Karin Jirström and Arne Östman Br J Cancer 2016 114: 1117-1124; advance online publication, April 26, 2016; 10.1038/bjc.2016.104 Abstract | Full Text Regulation of the T-box transcription factor Tbx3 by the tumour suppressor microRNA-206 in breast cancer Sumaira Amir, Catalina Simion, Maxine Umeh-Garcia, Sheryl Krig, Tyler Moss, Kermit L Carraway, III and Colleen Sweeney Br J Cancer 2016 114: 1125-1134; advance online publication, April 21, 2016; 10.1038/bjc.2016.73 Abstract | Full Text Regulation of E3 ubiquitin ligase-1 (WWP1) by microRNA-452 inhibits cancer cell migration and invasion in prostate cancer Yusuke Goto, Satoko Kojima, Akira Kurozumi, Mayuko Kato, Atsushi Okato, Ryosuke Matsushita, Tomohiko Ichikawa and Naohiko Seki Br J Cancer 2016 114: 1135-1144; advance online publication, April 12, 2016; 10.1038/bjc.2016.95 Abstract | Full Text The presence of intraepithelial CD45RO+ cells in resected lymph nodes with metastases from NSCLC patients is an independent predictor of disease-specific survival Thomas K Kilvaer, Erna-Elise Paulsen, Mehrdad R Khanehkenari, Samer Al-Saad, Ramona M Johansen, Khalid Al-Shibli, Roy M Bremnes, Lill-Tove Busund and Tom Donnem Br J Cancer 2016 114: 1145-1151; advance online publication, April 7, 2016; 10.1038/bjc.2016.92 Abstract | Full Text The role of chemerin and ChemR23 in stimulating the invasion of squamous oesophageal cancer cells J Dinesh Kumar, Sandhir Kandola, Laszlo Tiszlavicz, Zita Reisz, Graham J Dockray and Andrea Varro Br J Cancer 2016 114: 1152-1159; advance online publication, April 19, 2016; 10.1038/bjc.2016.93 Abstract | Full Text Genetics and Genomics Top The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study Javaid Iqbal, Andre Nussenzweig, Jan Lubinski, Tomasz Byrski, Andrea Eisen, Louise Bordeleau, Nadine M Tung, Siranoush Manoukian, Catherine M Phelan, Ping Sun, Steven A Narod and The Hereditary Breast Cancer Research Group Br J Cancer 2016 114: 1160-1164; advance online publication, March 17, 2016; 10.1038/bjc.2016.58 Abstract | Full Text Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicity Mahbubl Ahmed, Leila Dorling, Sarah Kerns, Laura Fachal, Rebecca Elliott, Matt Partliament, Barry S Rosenstein, Ana Vega, Antonio Gómez-Caamaño, Gill Barnett, David P Dearnaley, Emma Hall, Matt Sydes, Neil Burnet, Paul D P Pharoah, Ros Eeles and Catharine M L West Br J Cancer 2016 114: 1165-1174; advance online publication, April 12, 2016; 10.1038/bjc.2016.94 Abstract | Full Text Letters to the Editor Top Comment on ‘Tumour antigen expression in hepatocellular carcinoma in a low-endemic western area’ F Grizzi, D Qehajaj, M Chiriva-Internati and S Stifter Br J Cancer 2016 114: e1; advance online publication, April 14, 2016; 10.1038/bjc.2015.441 Full Text Reply to: Comment on ‘Tumour antigen expression in hepatocellular carcinoma in a low-endemic western area’ Kostandinos Sideras, Marco J Bruno and Jaap Kwekkeboom Br J Cancer 2016 114: e2; advance online publication, April 14, 2016; 10.1038/bjc.2015.442 Full Text Comment on ‘Diagnosis of pathological complete response to neoadjuvant chemotherapy in breast cancer by minimal invasive biopsy techniques’ Henry M Kuerer, Wei T Yang and Savitri Krishnamurthy Br J Cancer 2016 114: e3; advance online publication, April 19, 2016; 10.1038/bjc.2015.475 Full Text Reply to Comment on ‘Diagnosis of pathological complete response to neoadjuvant chemotherapy in breast cancer by minimal invasive biopsy techniques’ Joerg Heil Br J Cancer 2016 114: e4; advance online publication, April 19, 2016; 10.1038/bjc.2015.476 Full Text Comment on ‘Circulating cell-free miRNAs as biomarker for triple-negative breast cancer’—Methodological challenges in combining miRNAs as circulating biomarkers P Verderio, S Bottelli, M Lecchi, M Plebani, M Gariboldi, S Pizzamiglio and C M Ciniselli Br J Cancer 2016 114: e5; advance online publication, April 21, 2016; 10.1038/bjc.2016.1 Full Text Response to: Comment on ‘Circulating cell-free miRNAs as biomarker for triple-negative breast cancer’ Vivian Y Shin and Ava Kwong Br J Cancer 2016 114: e6; advance online publication, April 21, 2016; 10.1038/bjc.2016.2 Full Text Comment on ‘Wild-type APC prediction of poor prognosis in microsatellite-stable proximal colorectal cancer differs according to the age of onset’ José Perea, María Arriba, Daniel Rueda, Ricardo Sánchez, Juan Luis García, Jessica Pérez, Yolanda Rodríguez, Rogelio González-Sarmiento and Miguel Urioste Br J Cancer 2016 114: e7; advance online publication, April 26, 2016; 10.1038/bjc.2016.53 Full Text Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.